Início › Câncer (todos os tipos) › Alabama › Birmingham
Ensaios clínicos de Câncer (todos os tipos) em Birmingham, AL
30 estudos para Câncer (todos os tipos) estão buscando participantes em locais em Birmingham e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecrutandoFase 2/3
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
RecrutandoFase 3
- UAB Medicine - UAB Hospital, Birmingham
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RecrutandoFase 3
- Quetzal Site 16, Birmingham
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RecrutandoFase 3
- Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063, Birmingham
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecrutandoFase 2
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RecrutandoFase 2/3
- University of Alabama Birmingham, Birmingham
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecrutandoFase 2
- UAB, Psychiatry and Behavioral Neurology, Birmingham
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
RecrutandoFase 1/2
- The University of Alabama at Birmingham ( Site 1005), Birmingham
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecrutandoFase 1
- University of Alabama at Birmingham Cancer Center, Birmingham
Project: Every Child for Younger Patients With Cancer
RecrutandoEstudo observacional
- Children's Hospital of Alabama, Birmingham
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
RecrutandoFase 2
- Childrens Hospital of Alabama, Birmingham
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecrutandoFase 3
- University of Alabama at Birmingham Cancer Center, Birmingham
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RecrutandoFase 2
- 004, Birmingham
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
RecrutandoFase 1
- University of Alabama at Birmingham, Birmingham
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Recrutando
- University of Alabama at Birmingham, Division of Hematology and Oncology, Birmingham
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
RecrutandoFase 1
- GSK Investigational Site, Birmingham
Childhood Cancer Survivor Study
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- University of Alabama at Birmingham/Children's of Alabama, Birmingham
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Recrutando
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
Multisite Implementation of COMPRENDO
RecrutandoVoluntários saudáveis bem-vindos
- Children's of Alabama/University of Alabama at Birmingham, Birmingham
Leading Healthy Eating and Activity Promotion Program
RecrutandoVoluntários saudáveis bem-vindos
- University of Alabama at Birmingham, Birmingham
Video Inspired Discussions About Ethical Outcomes in Pediatrics
Recrutando
- Children's of Alabama at Birmingham, Birmingham
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RecrutandoFase 2
- University of Alabama at Birmingham, Birmingham
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recrutando
- University of Alabama at Birmingham, Birmingham
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
Recrutando
- University of Alabama at Birmingham, Birmingham
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
RecrutandoEstudo observacional
- Alabama Oncology, Birmingham
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
Recrutando
- The Kirklin Clinic, Birmingham
GEMINI-NSCLC: NSCLC Biomarker Study
RecrutandoEstudo observacional
- Alabama Oncology, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Birmingham
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Recrutando
- University of Alabama at Brimingham, Birmingham
Making Healthy Habits Stick
Recrutando
- University of Alabama at Birmingham, Birmingham
Ensaios de Câncer (todos os tipos) em outras cidades
- Houston, TX121 estudos
- New York City, NY110 estudos
- Boston, MA86 estudos
- Los Angeles, CA73 estudos
- Nashville, TN65 estudos
- Philadelphia, PA59 estudos
- Durham, NC58 estudos
- Washington, DC58 estudos
- Chicago, IL51 estudos
- Seattle, WA49 estudos
- Atlanta, GA49 estudos
- Arlington, VA48 estudos
Outros estudos em Birmingham
- Câncer de Mama24 estudos
- Obesidade23 estudos
- Câncer de Ovário23 estudos
- Câncer de Pulmão de Não Pequenas Células22 estudos
- Leucemia Mieloide Aguda21 estudos
- Mieloma Múltiplo18 estudos
- DPOC17 estudos
- Doença Cardiovascular17 estudos
- Sobrepeso16 estudos
- Câncer Endometrial16 estudos
- Diabetes tipo 216 estudos
- Fibrose Cística16 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.